Galectin Therapeutics
GALT
#8130
Rank
C$0.24 B
Marketcap
$3.90
Share price
0.73%
Change (1 day)
52.51%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.15 Billion

According to Galectin Therapeutics's latest financial reports the company's total liabilities are C$0.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$72.56 M45.22%
2021-12-31C$49.97 M624.83%
2020-12-31C$6.89 M83.8%
2019-12-31C$3.75 M30.63%
2018-12-31C$2.87 M-23.05%
2017-12-31C$3.73 M-26.54%
2016-12-31C$5.07 M169.26%
2015-12-31C$1.88 M-4.54%
2014-12-31C$1.97 M-25.32%
2013-12-31C$2.64 M61.88%
2012-12-31C$1.63 M-27.44%
2011-12-31C$2.25 M-71.8%
2010-12-31C$7.99 M54.89%
2009-12-31C$5.15 M261.71%
2008-12-31C$1.42 M-69.62%
2007-12-31C$4.69 M-36.85%
2006-12-31C$7.43 M362.7%
2005-12-31C$1.6 M33.1%
2004-12-31C$1.2 M146.18%
2003-12-31C$0.49 M-53.44%
2002-12-31C$1.05 M20.04%
2001-12-31C$0.87 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.25 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.94 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA